IBIO
iBio, Inc.
1.10$
+1.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -100.0% | – | – | -100.0% | – | -100.0% | – | -50.0% | -100.0% | – | – | – | |
| – | +54.8% | -14.2% | -15.4% | – | – | – | – | – | -16.6% | +3.7% | -412.0% | – | |
| – | – | – | – | – | – | – | – | -194.5% | – | – | – | – | |
| – | -4.4% | -41.1% | +26.1% | +14.5% | +43.8% | +1.5% | +69.2% | +10.1% | +20.6% | -24.0% | +163.0% | – | |
| – | -16.5% | -8.1% | -10.2% | +14.6% | -2.1% | +8.4% | -26.9% | +15.0% | +106.5% | -1.0% | -57.3% | – | |
| – | -8.3% | -19.4% | -8.9% | +24.3% | +12.5% | +5.6% | +10.6% | +6.7% | +16.3% | -16.3% | +205.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +30.8% | +52.9% | +15.4% | -5.0% | +0.0% | -5.3% | -18.5% | -18.2% | +13.9% | -46.3% | +109.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -95.3% | +1,479.4% | -341.7% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.